// App-Quantinova.ai

248 : Lenalidomide In Combination With R-CHOP (R2-CHOP) In Patients With High Burden Follicular Lymphoma: Phase 2 Study

Researchers

Presenter

  • Herve Tilly

Principal Investigators

  • Franck Morschhauser

  • Olivier Casasnovas

  • Jean Gabarre

  • Thierry Lamy

  • Corinne Haioun

  • Thierry Jo Molina

  • Nicolas Mounier

  • Gilles Andre Salles

  • Steven Le Gouill

  • Serge Bologna

  • Olivier Tournilhac

  • Jose Cabecadas

  • Reda Bouabdallah

Medical Centers

  • Centre Henri Becquerel, Inserm U, Universite de Rouen, IRIB, Rouen, France

  • Servico de Anatomia Patologica, Instituto Portugues de Oncologia de Lisboa de Francisco Gentil, Lisbon, Portugal

  • Pathology, Universite Paris Descartes, AP-HP, Hopital Hotel-Dieu, Paris, France

  • Hematology Clinic, CHU Nantes, Nantes, France

  • Service -Hematologie, CHU de Nancy, Hopital de Brabois, Vandoeuvre-les-Nancy, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Hematology, University Hospital, Clermont Ferrand, France

  • Department of Urology, CHU Pontchaillou, Rennes, France

  • Institut Paoli-Calmettes, Marseille, France

  • Hematology, Hopital Pitie-Salptriere, Paris, France

  • Departement -Hematologie, CHU de Nice, Nice, France

  • Hopital Claude Huriez, Lille, France

  • Dermatology, CHU Dijon, Dijon, France

  • Hematology, Hopital Henri Mondor, Creteil Cedex, France

Locations

  • France

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

  • B cell lymphomas

  • Thrombocytopenia

  • Neutropenia

  • Peripheral neuropathy

  • Venous thrombosis

  • Lymphomas

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Pegfilgrastim

  • Lenalidomide

  • Rituximab

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • open label

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved